- Ping An Insurance has reached a year-to-date life premium income of 472.1 billion yuan.
- The company’s property and casualty insurance has generated a premium income of 292.3 billion yuan so far this year.
- Among analysts, there are 23 “buy” recommendations for Ping An Insurance.
- There are 2 “hold” recommendations, reflecting some confidence in maintaining current positions.
- No analysts currently recommend selling Ping An Insurance, indicating positive market sentiment.
A look at Ping An Insurance (H) Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, Ping An Insurance (H) appears to have a promising long-term outlook. With a top score in both Value and Dividend factors, the company showcases strong fundamentals and a commitment to rewarding investors. Additionally, solid scores in Growth and Resilience indicate a stable and growing business model, backed by a well-diversified portfolio of insurance services in China. Although Momentum lags slightly behind, the overall outlook for Ping An Insurance (H) suggests a robust and reliable investment opportunity in the insurance sector.
Ping An Insurance (H) of China stands out for its exceptional value proposition and dividend performance, positioning itself as a key player in the insurance industry. The company’s emphasis on growth and resilience further cements its reputation as a reliable choice for investors seeking long-term stability and potential returns. With a strategic focus on providing comprehensive insurance services in China, Ping An Insurance (H) demonstrates a strong financial footing and a commitment to delivering value to its shareholders.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
